Follicular and mantle cell lymphoma. Extranodal involvement of primarily nodal indolent B-cell lymphomas;Follikuläre lymphome und mantelzelllymphome. Extranodale manifestationen primär nodaler indolenter B-zell-lymphome

Pathologe

Volumn 28, Issue 1, 2007, Pages 21-28

  Klapper, W ^a   Wacker, H H ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

B cell lymphomas; Follicular lymphoma; Lymph nodes; Mantle cell lymphoma

Indexed keywords

ARTICLE; B CELL LYMPHOMA; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GRADING; CANCER GROWTH; CANCER LOCALIZATION; CLINICAL FEATURE; FOLLICULAR LYMPHOMA; HUMAN; IMMUNOPHENOTYPING; INTERNATIONAL CLASSIFICATION OF DISEASES; LYMPHOCYTOMA; MANTLE CELL LYMPHOMA; MORPHOLOGY; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; TUMOR BIOPSY;

BIOPSY; CELL DIVISION; HUMANS; IMMUNOPHENOTYPING; LYMPH NODES; LYMPHOMA, B-CELL; LYMPHOMA, FOLLICULAR; LYMPHOMA, MANTLE-CELL;

EID: 33847242969     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00292-006-0878-2     Document Type: Article

References (15)

1. Jaffe E, Harris N, Stein H, Vardiman JW (2001) Pathology and genetics of tumours of haematopoetic and lymphoid tissues. IARC, Lyon
2. Raderer M, Wohrer S, Streubel B et al. (2006) Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging: a single-center experience. J Clin Oncol 24): 3136-3141
3. Bertoni F, Gisi M, Roggero E et al. (2000) Molecular detection of circulating neoplastic cells in patients with clinically localised gastric and non-gastric mucosa-associated lymphoid tissue lymphoma. Dig Liver Dis 32: 188-191
4. Pott C, Schrader C, Gesk S et al. (2006) Quantitative assessment of molecular remission after high-dose therapy with autologous stem cell transplantation predicts long-term remission in mantle cell lymphoma. Blood 107: 2271-2278
5. Adam P, Katzenberger T, Eifert M et al. (2005) Presence of preserved reactive germinal centers in follicular lymphoma is a strong histopathologic indicator of limited disease stage. Am J Surg Pathol 29: 1661-1664
6. Nenova I, Mateva N, Ananoshtev N, Grudeva-Popova J (2005) The prognostic value of clinical and laboratory parameters in patients with chronic lymphocytic leukemia. Hematology 10: 47-51
7. Harris NL, Bhan AK (1985) B-cell neoplasms of the lymphocytic, lymphoplasmacytoid, and plasma cell types: immunohistologic analysis and clinical correlation. Hum Pathol 16: 829-837
8. Koch P, del Valle F, Berdel WE et al. (2001) Primary gastrointestinal non-Hodgkin's lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92. J Clin Oncol 19: 3861-3873
9. A clinical evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma (1997) The Non-Hodgkin's Lymphoma Classification Project. Blood 89: 3909-3918
10. Tracey L, Perez-Rosado A, Artiga MJ et al. (2005) Expression of the NF-kappa B targets BCL2 and BIRC5/survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively. J Pathol 206: 123-134
11. Tiemann M, Schrader C, Klapper W et al. (2005) Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network. Br J Haematol 131: 29-38
12. Morice WG, Hodnefield JM, Kurtin PJ, Hanson CA (2004) An unusual case of leukemic mantle cell lymphoma with a blastoid component showing loss of CD5 and aberrant expression of CD10. Am J Clin Pathol 122: 122-127
13. Fu K, Weisenburger DD, Greiner TC et al. (2005) Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. Blood 106: 4315-4321
14. Gesk S, Klapper W, Martin-Subero JI et al. (2006) A chromosomal translocation in cyclin D1-negative/cyclin D2-positive mantle cell lymphoma fuses the CCND2 gene to the IGK locus. Blood 108: 1109-1110
15. Schrader C, Meusers P, Brittinger G et al. (2004) Topoisomerase II alpha expression in mantle cell lymphoma: a marker of cell proliferation and a prognostic factor for clinical outcome. Leukemia 18: 1200-1206